Skip to content

Company newsroom

Werewolf Therapeutics, Inc.

NASDAQ:HOWL

1 releases

Werewolf Therapeutics, Inc.18h ago

Werewolf Therapeutics’ Clinical Data for WTX-124 and WTX-330 Presented at the Society for Immunotherapy of Cancer’s (SITC) 2026 Annual Meeting